相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Structure of arylamine N-acetyltransferase from Mycobacterium tuberculosis determined by cross-seeding with the homologous protein from M. marinum: triumph over adversity
Areej Abuhammad et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2013)
First novel anti-tuberculosis drug in 40 years
Randy Osborne
NATURE BIOTECHNOLOGY (2013)
Totally Drug-Resistant Tuberculosis in India
Zarir F. Udwadia et al.
CLINICAL INFECTIOUS DISEASES (2012)
Freely Available Conformer Generation Methods: How Good Are They?
Jean-Paul Ebejer et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2012)
Piperidinols That Show Anti-Tubercular Activity as Inhibitors of Arylamine N-Acetyltransferase: An Essential Enzyme for Mycobacterial Survival Inside Macrophages
Areej Abuhammad et al.
PLOS ONE (2012)
Novel Small-Molecule Inhibitors of Arylamine N-Acetyltransferases: Drug Discovery by High Throughput Screening
Isaac M. Westwood et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2011)
The Bacillus anthracis arylamine N-acetyltransferase ((BACAN)NAT1) that inactivates sulfamethoxazole, reveals unusual structural features compared with the other NAT isoenzymes
Benjamin Pluvinage et al.
FEBS LETTERS (2011)
Challenges and opportunities in developing novel drugs for TB
Takushi Kaneko et al.
FUTURE MEDICINAL CHEMISTRY (2011)
Improving the accuracy of ultrafast ligand-based screening: incorporating lipophilicity into ElectroShape as an extra dimension
M. Stuart Armstrong et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2011)
An Overview of Tuberculosis Chemotherapy - A Literature Review
Susmita Sarkar et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2011)
The resurgence of covalent drugs
Juswinder Singh et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Improvement of the expression and purification of Mycobacterium tuberculosis arylamine N-acetyltransferase (TBNAT) a potential target for novel anti-tubercular agents
Areej Abuhammad et al.
PROTEIN EXPRESSION AND PURIFICATION (2011)
ElectroShape: fast molecular similarity calculations incorporating shape, chirality and electrostatics
M. Stuart Armstrong et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2010)
Prospective virtual screening with Ultrafast Shape Recognition: the identification of novel inhibitors of arylamine N-acetyltransferases
Pedro J. Ballester et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2010)
The Population Dynamics and Control of Tuberculosis
Christopher Dye et al.
SCIENCE (2010)
Probing the architecture of the Mycobacterium marinum arylamine N-acetyltransferase active site
Areej M. Abuhammad et al.
PROTEIN & CELL (2010)
Identification of arylamine N-acetyltransferase inhibitors as an approach towards novel anti-tuberculars
Isaac M. Westwood et al.
PROTEIN & CELL (2010)
Extensively Drug-Resistant Tuberculosis: A New Face to an Old Pathogen
Sheela Shenoi et al.
ANNUAL REVIEW OF MEDICINE (2009)
Selective small molecule inhibitors of the potential breast cancer marker, human arylamine N-acetyltransferase 1, and its murine homologue, mouse arylamine N-acetyltransferase 2
Angela J. Russell et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Molecular similarity including chirality
M. Stuart Armstrong et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2009)
The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis
Andreas H. Diacon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Comparison of the Arylamine N-Acetyltransferase from Mycobacterium marinum and Mycobacterium tuberculosis
Elizabeth Fullam et al.
PROTEIN JOURNAL (2009)
Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
Vadim Makarov et al.
SCIENCE (2009)
Studies of a Ring-Cleaving Dioxygenase Illuminate the Role of Cholesterol Metabolism in the Pathogenesis of Mycobacterium tuberculosis
Katherine C. Yam et al.
PLOS PATHOGENS (2009)
Divergence of cofactor recognition across evolution:: Coenzyme a binding in a prokaryotic arylamine N-acetyltransferase
Elizabeth Fullam et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Characterization of the putative operon containing arylamine N-acetyltransferase (nat) in Mycobacterium bovis BCG
MC Anderton et al.
MOLECULAR MICROBIOLOGY (2006)
Evaluation of antimicrobial activities of several Mannich bases and their derivatives
HI Gul et al.
ARCHIV DER PHARMAZIE (2005)
The crystal structures of human steroidogenic factor-1 and liver receptor homologue-1
W Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Eukaryotic arylamine N-acetyltransferase investigation of substrate specificity by high-throughput screening
A Kawamura et al.
BIOCHEMICAL PHARMACOLOGY (2005)
A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis
K Andries et al.
SCIENCE (2005)
An efficient and environmental-friendly synthesis of 4-hydroxy-arylpiperidines using hydrotalcite catalyst
A Cwik et al.
JOURNAL OF MOLECULAR CATALYSIS A-CHEMICAL (2004)
Arylamine N-acetyltransferase is required for synthesis of mycolic acids and complex lipids in Mycobacterium bovis BCG and represents a novel drug target
S Bhakta et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Anti-inflammatory activity of 3-benzoyl-1-methyl-4-phenyl-4-piperidinol hydrochloride
H Suleyman et al.
PHARMACOLOGICAL RESEARCH (2003)
An approach to identifying novel substrates of bacterial arylamine N-acetyltransferases
EW Brooke et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2003)
分享论文
